ProtocolNow Announces Daniel F. O’Keeffe, M.D. as Chairman of the Board

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NASHVILLE, Tenn., Sept. 17, 2020 /PRNewswire/ — ProtocolNow, leading provider of real-time protocols accessible anytime, anywhere, has appointed Daniel O’Keeffe as Chairman of the board. Dr. O’Keeffe, an obstetrician-gynecologist with over 20 years experience, will leverage his relationships and experience in the field to lead the strategic growth and adoption of ProtocolNow as the standard for managing protocols.

The announcement follows the recent appointments of Charles Lukens as CEO and PJ Likhmania as CIO, to solidify the leadership team.

“As an early adopter of technology to assist in operating his medical practice, O’Keeffe’s experience will offer critical direction as the business scales,” said CIO PJ Likhmania. He added that “leveraging O’Keeffe’s direct connections to the front line of providing medical service brings agility to our product research and development.”

O’Keeffe has practiced medicine and led teams of physicians in both California and Arizona. He completed his residency at University of California Irvine, and is now a partner in his practice in Scottsdale, AZ. As a specialist in maternal-fetal medicine, O’Keeffe shared his excitement for ProtocolNow to change the mantra in the medical industry around protocols from “static checklists to living and changing plans that, coupled with our technology, deliver measurable improvement to standardizing care and improving patient outcomes.”

About ProtocolNow
ProtocolNow is a software platform that houses the protocol lifecycle. In business, protocols are everywhere, and properly managed and followed protocols deliver more consistent service and results. ProtocolNow empowers clients to develop, train on, apply and refine protocols with their easy-to-use proprietary platform. Learn more at ProtocolNow.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/protocolnow-announces-daniel-f-okeeffe-md-as-chairman-of-the-board-301133125.html

SOURCE ProtocolNow.com

Staff

Recent Posts

Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040

RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on…

2 hours ago

Olympia Pharmaceuticals Secures $637,000 Workforce Training Grant to Boost Job Creation in Orlando

The funding will train 100 new employees at Wesley Pharmaceuticals, supporting local talent and healthcare…

2 hours ago

Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000…

2 hours ago

Connect Biopharma to Present at Two Upcoming Investor Conferences in June

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect…

2 hours ago

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer…

2 hours ago

Flare Therapeutics to Participate in Jefferies Global Healthcare Conference

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology…

2 hours ago